SS
XFOR icon

SBI Securities’s X4 Pharmaceuticals XFOR Stock Holding History

SBI Securities’s Portfolio XFOR Stock Details XFOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$42 Sell
9
-45
-83% -$185 ﹤0.01% 3711
2026
Q1 		$223 Buy
54
+4
+8% +$15 ﹤0.01% 3183
2025
Q4 		$200 Sell
50
-166
-77% -$603 ﹤0.01% 3211
2025
Q3 		$739 Hold
216
– – ﹤0.01% 2817
2025
Q2 		$410 Buy
216
+2
+0.9% +$8 ﹤0.01% 3043
2025
Q1 		$1.52K Buy
214
+177
+478% +$2.44K ﹤0.01% 2418
2024
Q4 		$823 Buy
+37
New +$590 ﹤0.01% 2695

Other funds holding XFOR

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

SBI Securities's XFOR Position: Q2 2026 in Review

SBI Securities reduced its X4 Pharmaceuticals (XFOR) stake by 83% in Q2 2026, selling an estimated $185 and leaving 9 shares worth $42. The position accounts for ﹤0.01% of the portfolio, ranked #3711.

SBI Securities first reported a position in XFOR in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.52K in Q1 2025. 89 funds tracked by Wall St. Rank hold XFOR as of Q2 2026.

  • SBI Securities held 9 shares of X4 Pharmaceuticals worth $42 as of Q2 2026.
  • SBI Securities sold 45 X4 Pharmaceuticals shares in Q2 2026, an estimated $185.
  • X4 Pharmaceuticals made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3711 holding.
  • SBI Securities first reported a position in X4 Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's X4 Pharmaceuticals position peaked at $1.52K in Q1 2025.
  • 89 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.